|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/00 | (2006.01) |
| A61K 38/29 | (2006.01) | ||
| A61P 19/08 | (2006.01) | ||
| A61P 19/10 | (2006.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61K 38/27 | (2006.01) | ||
| A61K 38/17 | (2006.01) |
| (11) | Number of the document | 3308796 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17190589.6 |
| Date of filing the European patent application | 2013-11-01 | |
| (97) | Date of publication of the European application | 2018-04-18 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-14 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201261721898 P | 2012-11-02 | US | |
| 201261740665 P | 2012-12-21 | US |
| (72) |
Schorr Sloan, Victor , US
Hruska, Keith , US
Fang, Yifu , US
Sung, Victoria , US
Stevens, Randall , US
Smith, William , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
Washington University , One Brookings Drive, Saint Louis, MO 63130, US |
| (54) | ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS |
| ACTIVIN-ACTRII ANTAGONISTS AND USES FOR TREATING BONE AND OTHER DISORDERS |